Tripathi Deepali, Misra Ankita, Chaudhary Mridul Kant, Srivastava Sharad
Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, UP, India.
Nat Prod Res. 2023 Aug-Sep;37(17):2894-2899. doi: 10.1080/14786419.2022.2134863. Epub 2022 Oct 19.
(Goetgh.) Colebr. is widely used for urinary disorders and kidney stones by ethnic communities in southern India. The species is documented in various ancient Indian Ayurvedic literatures having therapeutic use in 'Ashmari' i.e., urolithiasis. The present study aims at validation of anti-urolithiatic potential of various extracts of stem along with identification and quantification of major bioactive alkaloids, i.e., berberine and palmatine through HPTLC and LC-MS/MS. Water extract showed maximum anti-urolithiatic activity which on further kinetic analysis, showed concentration dependent inhibitory delay in nucleation and aggregation of calcium oxalate crystals. Berberine and palmatine were quantified with maximum content in methanolic extract (0.478 ± 0.003 and 0.0358 ± 0.001) followed by chloroform and petroleum ether extracts. The study validates ethnobotanical use of as anti-urolithiatic agent. Further, species can also be explored as a substitute for spp. for the alkaloid metabolites i.e., berberine and palmatine.
(Goetgh.) Colebr. 在印度南部的少数民族社区中被广泛用于治疗泌尿系统疾病和肾结石。该物种在各种古印度阿育吠陀文献中均有记载,对 “Ashmari” 即尿石症有治疗作用。本研究旨在验证该植物茎的各种提取物的抗尿石症潜力,并通过高效薄层色谱法(HPTLC)和液相色谱 - 串联质谱法(LC-MS/MS)对主要生物活性生物碱小檗碱和巴马汀进行鉴定和定量。水提取物显示出最大的抗尿石症活性,进一步的动力学分析表明,其对草酸钙晶体的成核和聚集具有浓度依赖性抑制延迟作用。小檗碱和巴马汀在甲醇提取物中的含量最高(分别为0.478 ± 0.003和0.0358 ± 0.001),其次是氯仿提取物和石油醚提取物。该研究验证了该植物作为抗尿石症药物的民族植物学用途。此外,该物种还可作为小檗属植物的替代品,用于生物碱代谢产物即小檗碱和巴马汀的研究。